No Data
Axcelis Technologies, Inc. (ACLS): An Oversold Midcap Stock to Buy
Axcelis Announces Participation in Upcoming Investor Conferences
Is the Options Market Predicting a Spike in Axcelis Technologies (ACLS) Stock?
Earnings Update: Axcelis Technologies, Inc. (NASDAQ:ACLS) Just Reported And Analysts Are Trimming Their Forecasts
A Quick Look at Today's Ratings for Axcelis Technologies(ACLS.US), With a Forecast Between $115 to $125
Axcelis: Steering Clear of Mine Safety Risks and Liabilities
72623473 : No use, internal personnel will deliberately create various troubles! Such as fire, such as leaking, and so on... Then they bottom out! Full of routines...
Steven J : I bought $Concentrix (CNXC.US)$ ,$Advanced Micro Devices (AMD.US)$ at these low levels. Sold my $Axcelis Technologies (ACLS.US)$ at 136. I like that one too. But here one of my favorite and is very undervalued $Certara (CERT.US)$ and unappreciated by wallstreet.
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries. The pipeline of getting drugs approved keeps going up and Biosimulation should be beneficiary. Do your own Homework